Evaluation of Lumitrace for Visualizing Ureters During Abdominopelvic Surgeries

Exclusion Criteria

• •1. Participant has any serious or uncontrolled physical or psychiatric condition that in the opinion of the investigator would limit the their ability to complete study requirements or may put the subject at increased risk, or compromise the interpretability of study results, which makes the participant unsuitable for study participation
• •2. Participant is anticipated to require ureteral stenting during surgery
• •3. Participant has an active urinary tract infection requiring antibiotic therapy
• •4. Participant has moderate to severe cardiac disease that limits daily functioning (New York Heart Association Class III to IV) or other medical conditions that would impact safety or study compliance
• •5. Participant has any clinically relevant laboratory abnormality that could contraindicate surgery in the opinion of the PI
• •6. Participant with body weight \< 30 kilogram (kg)
• •7. History of severe allergic hypersensitivity reactions (unacceptable adverse events) or anaphylactoid reaction to any allergen including drugs, Lumitrace or other related products (intolerance to a drug is not considered a drug allergy)
• •8. Participant has received any investigational therapy within 30 days or 5 half-lives, whichever is longer, prior to screening
• •9. eGFR \<60 mL/min/1.73m2
• •10. Participants with positive serum pregnancy test